amiodarone has been researched along with venlafaxine hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baranchuk, A; Digby, G; Machaalany, J; Malik, P; Methot, M; Redfearn, D; Simpson, CS | 1 |
| Delafontaine, P; Deo, R; Doerfler, RM; Fink, JC; Fischer, MJ; Jaar, BG; Kramlik, S; Makos, GK; Navaneethan, S; Ojo, A; Slaven, A; Snitker, S; Soliman, EZ; St Peter, WL; Weir, MR; Zhan, M | 1 |
2 other study(ies) available for amiodarone and venlafaxine hydrochloride
| Article | Year |
|---|---|
Multifactorial QT interval prolongation.
Topics: Alcoholism; Amiodarone; Antipsychotic Agents; Arrhythmias, Cardiac; Biomarkers; Citalopram; Cyclohexanols; Dibenzothiazepines; Diuretics; Domperidone; Dopamine Antagonists; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypokalemia; Magnesium; Middle Aged; Polypharmacy; Quetiapine Fumarate; Risk Factors; Selective Serotonin Reuptake Inhibitors; Torsades de Pointes; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents, Second-Generation; Citalopram; Diabetes Complications; Diuretics; Electrocardiography; Female; Fluoxetine; Furosemide; Heart; Heart Rate; Histamine H1 Antagonists; Humans; Hydroxyzine; Male; Metolazone; Middle Aged; Proton Pump Inhibitors; Renal Insufficiency, Chronic; Venlafaxine Hydrochloride | 2017 |